Most Download

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

In last 3 years
Please wait a minute...
For Selected: Toggle Thumbnails
2024, 12 (3): 271-275. DOI: 10.3969/j.issn.2095-5332.2024.03.019
Abstract51)      PDF (919KB)(105)      

Clinical application of metagenomic second-generation sequencing technology in the diagnosis and treatmentof pulmonary infections after kidney transplantation 

Li Jiazhi, Ou Shengsong, Qin Chaoyu, Wei Xiaojiao, Pang Feixiong, Ran Guo, Yang Jianrong, Lai Yanhua.
2024, 12 (3): 204-208. DOI: 10.3969/j.issn.2095-5332.2024.03.003
Abstract46)      PDF (793KB)(53)      

ObjectiveTo Explore the clinical value of metagenomic second-generation sequencing technology (mNGS) in the diagnosis and treatment of pulmonary infections after kidney transplantation, and to provide reference for precise diagnosis and treatment of diseases. MethodsThe clinical data of 124 kidneytransplant recipients with pulmonary infections were completed from the Department of Transplantation of the People's Hospital of Guangxi Zhuang Autonomous Region from January 1,2020 to December 15,2023. According to the pathogen detection method of mNGS, the patients were divided into sequencing group (60 cases) and traditional group (64 cases). The pathogen detection rate, antibiotic use intensity, hospitalization time, hospitalization cost, non-invasive respiratory support rate, disease grade, severe illness rate, mortality rate, and other indicators were retrospectively analyzed between traditional group and sequencing group. ResultsThere was no statistically significant difference in gender, age,postoperative onset time, underlying disease, admission status of pulmonary infection (SMART-COP score), pre-treatment creatinine, tacrolimus concentration, and methylprednisolone regimen between the two groups of patients (P>0.05). The detection of pathogens and mixed pulmonary infections in the sequencing group was significantly higher than that in the traditional group (P < 0.05). However, there was no statistically significant difference in the results of traditional detection methods between the two groups (P>0.05). There was statistically significant difference in the bronchoalveolar lavage fluid pathogens, mixed lung infections, pneumocystis jejun between the mNGS and culture + smear methods (P<0.05). One adverse reaction occurred in the sequencing group, with no complications related to bronchoscopy, and two adverse reactions occurred in the traditional group. In the sequencing group, the intensity of antibiotic use, mortality,peak pulmonary infection progression, discharge creatinine, length of hospital stay, and hospitalization costs were significantly lower than those of the traditional group (P < 0.05), and the non-invasive respiratory support for patients and critically ill patients were similar to the traditional group (P>0.05). ConclusionmNGS can provide precise directions for the diagnosis and treatment of kidney transplant recipients with pulmonary infections, it improves patient clinical prognosis, and is worthy of clinical promotion. 

2025, 13 (1): 1-6. DOI: 10.3969/j.issn.2095-5332.2025.01.001
Abstract46)      PDF (1006KB)(51)      
2025, 13 (2): 97-102. DOI: 10.3969/j.issn.2095-5332.2025.02.001
Abstract52)      PDF (940KB)(47)      
2025, 13 (2): 103-108. DOI: 10.3969/j.issn.2095-5332.2025.02.002
Abstract42)      PDF (915KB)(40)      
2024, 12 (5): 388-389. DOI: 10.3969/j.issn.2095-5332.2024.05.002
Abstract29)      PDF (910KB)(40)      
2024, 12 (3): 281-284. DOI: 10.3969/j.issn.2095-5332.2024.03.020
Abstract48)      PDF (709KB)(39)      
2024, 12 (5): 385-387. DOI: 10.3969/j.issn.2095-5332.2024.05.001
Abstract37)      PDF (931KB)(38)      
2024, 12 (5): 470-476. DOI: 10.3969/j.issn.2095-5332.2024.05.020
Abstract23)      PDF (734KB)(37)      
2024, 12 (3): 198-203. DOI: 10.3969/j.issn.2095-5332.2024.03.002
Abstract44)      PDF (1081KB)(35)      
2024, 12 (3): 250-. DOI: 10.3969/j.issn.2095-5332.2024.03.012
Abstract46)      PDF (623KB)(35)      
2024, 12 (3): 251-254. DOI: 10.3969/j.issn.2095-5332.2024.03.013
Abstract30)      PDF (1160KB)(31)      

Analysis of risk factors for loss of renal graft caused by chronic rejection 

Lu Yifan, Liu Yiting, Chen Zhongbao, Ma Xiaoxiong, Zhang Long, Zou Jilin, Zhou Jiangqiao, Qiu Tao .
2024, 12 (4): 315-319. DOI: 10.3969/j.issn.2095-5332.2024.04.006
Abstract51)      PDF (912KB)(31)      

Objective To investigate the main causes of kidney transplantation graft loss,and analyze independent risk factors for loss of graft by chronic rejection. Methods The prognosis of all kidney transplantrecipients from January 2015 to January 2023 was retrospectively analyzed. A total number of 14 recipients with renal graft loss due to chronic rejection were selected as the case group,and 56 recipients corresponding to 28 donors without donor kidney loss were selected as the control group. Clinical data of the two groups of recipients and corresponding donors were retrospectively analyzed,and logistic regression analysis was carried out. Results Inthe past 8 years147 cases experienced renal graft loss,including 67 cases of renal graft dysfunction and 80 cases of death. The top three causes of renal graft dysfunction were chronic rejection,vascular embolism and relapse of nephropathy. The top three causes of death in transplant patients were infection,cardiovascular accidents and digestive complications. Multivariate logistic regression analysis showed that there was a statistically significant difference in donor age between the case group and the control group(P 0.012). Conclusion In our center chronic rejection was the main cause of renal graft failure. The leading causes of death in kidney transplant patients are infection and cardiovascular problems. Age of the donors is the independent risk factor for renal graft loss bychronic rejection. 

2024, 12 (3): 193-197. DOI: 10.3969/j.issn.2095-5332.2024.03.001
Abstract45)      PDF (973KB)(31)      

Analysis of lung infection in allogeneic kidney transplantation patients and sharing of treatment experience 

Ma Yinrui , Hu Wei , Song Wenbin , Yin Limin , Song Yonglin , Li Haotian , Tan Shuncheng , Ma Xingyong , Sun Xun .
2024, 12 (3): 225-229. DOI: 10.3969/j.issn.2095-5332.2024.03.007
Abstract65)      PDF (791KB)(30)      

肾移植 肺部感染 宏基因二代测序 治疗经验

2024, 12 (5): 477-480. DOI: 10.3969/j.issn.2095-5332.2024.05.021
Abstract18)      PDF (712KB)(30)      

Establish model and summarize the experience of abdominal heterotopic heart transplantation in mice

Luo Zilong, Hao Yanglin, Zhang Xi, Wu Jie, Xia Chengkun, Zhao Yang, Xia Jiahong.
2025, 13 (2): 109-113. DOI: 10.3969/j.issn.2095-5332.2025.02.003
Abstract43)      PDF (1914KB)(29)      

Objective Establish model of abdominal heterotopic heart transplantation in mice and summarize the experience to provide animal model support for further study of organ transplantation immunology. Methods Inbred BALB/c(n = 30)and C57BL/6(n = 30)mice were selected as donors,and inbred BALB/c(n = 60)mice were used as recipients. The ascending aorta of the donor was anastomosed to the abdominal aorta of the recipient,and the pulmonary artery of the donor was anastomosed to the inferior vena cava of the recipient respectively to establish the heterotopic heart transplantation model. The survival time and the rejection of grafts were observed postoperatively. Results The successful rate of transplantation was 85%(51/60). The donoroperation time was(7.0±1.0)min,and the recipient operation time was(60±10)min. The vascular anastomosis time was(25±3.0)min. After the transplantation,no immunosuppressive agent was used,and the survival time of the graft was(7.6±0.9)d. The graft on the fifth day,the seventh day showed typical rejection by histopathology. Conclusion Skilled microsurgical techniques and timely management of surgical complications are key to the successful establishment of abdominal heterotopic heart transplantation in mice. 

2024, 12 (3): 262-265. DOI: 10.3969/j.issn.2095-5332.2024.03.016
Abstract41)      PDF (770KB)(28)      
2024, 12 (6): 481-484. DOI: 10.3969/j.issn.2095-5332.2024.06.001
Abstract34)      PDF (982KB)(26)      

Analysis of risk factors for recurrent pneumonia in elderly kidney transplant recipients after surgery 

Liu Yanzhong , Li Chao , Dong Hongmei , Chen Changqing .
2025, 13 (1): 7-11. DOI: 10.3969/j.issn.2095-5332.2025.01.002
Abstract45)      PDF (720KB)(25)      

Objective To explore the risk factors for recurrent ≥ 2 times) pneumonia in elderlykidney transplant recipients after surgery. Methods Retrospective analysis was performed from the clinical data of 119 elderly kidney transplant recipients who underwent kidney transplantation at the Eighth Medical Center of the People's Liberation Army General Hospital from January 2010 to January 2024. According to whether pneumonia occurs repeatedly (≥ 2 times) after kidney transplantation, elderly recipients were divided into two groups, with 11 cases in the recurrent pneumonia group and 108 cases in the non-recurrent pneumonia group. Relevant clinical data were compared between the two groups, including the general basic information of the recipient (gender, age, height, weight, smoking history,etc.), as well as the relevant clinical data (the time of dialysis before kidney transplantation, the maintenance treatment plan of immunosuppressant after surgery, whether there was delayed recovery of kidney function after transplantation, whether there was a decrease in white blood cells after transplantation, serum creatinine level at discharge, whether there was diabetes before and after surgery, and whether there was viral hepatitis B infection, etc.). We conducted univariate analysis and multivariate logistic regression analysis to explore the risk factors for recurrent pneumonia in elderly kidneytransplant recipients after surgery. Results The incidence of recurrent pneumonia in elderly kidney transplant recipientsafter surgery was 9.24% (11/119), and one patient in the case group died from severe pneumonia, with a mortality rate of 9.1% (1/11). Smoking history (OR = 13.15,95% CI = 2.406 ~ 71.91,P = 0.003) and postoperative leukopenia (OR = 6.050,95% CI = 1.248 ~ 29.32,P = 0.025) were risk factors for recurrent pneumonia in elderly kidney transplant recipients. Conclusion Smoking history and postoperative leukopenia increase the risk of recurrent pneumonia in elderly kidney transplant recipients. So we should strengthen postoperative health education for elderly kidney transplant recipients, encourage smoking cessation, and prevent and treat postoperative leukopenia.